{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:51:39Z","timestamp":1767919899669,"version":"3.49.0"},"reference-count":26,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2020,5,25]]},"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Many emergency physicians use an intravenous fluid bolus as part of a \u2018cocktail\u2019 of therapies for patients with headache, but it is unclear if this is beneficial. The objective of this study was to determine if an intravenous fluid bolus helps reduce pain or improve other outcomes in patients who present to the ED with a benign headache.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a randomised, single-blinded, clinical trial performed on patients aged 10\u201365 years old with benign headaches who presented to a single ED in Las Vegas, Nevada, from May 2017 to February 2019. All patients received prochlorperazine and diphenhydramine, and they were randomised to also receive either 20\u2009mL\/kg up to 1000\u2009mL of normal saline (the fluid bolus group) or 5\u2009mL of normal saline (the control group). The primary outcome was the difference between groups in mean pain reduction 60\u2009min after the initiation of treatment. Secondarily, we compared groups with regards to pain reduction at 30\u2009min, nausea scores, the use of rescue medications and disposition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We screened 67 patients for enrolment, and 58 consented. Of those, 35 were randomised to the fluid bolus group and 23 to the control group. The mean pain score dropped by 48.3\u2009mm over 60\u2009min in the fluid bolus group, compared with 48.7\u2009mm in the control group. The between groups difference of 0.4\u2009mm (95%\u2009CI \u221216.5 to 17.3) was not statistically significant (p=0.96). Additionally, no statistically significant difference was found between groups for any secondary outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Though our study lacked statistical power to detect small but clinically significant differences, ED patients who received an intravenous fluid bolus for their headache had similar improvements in pain and other outcomes compared with those who did not.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03185130\">NCT03185130<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2019-209389","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T21:23:36Z","timestamp":1593811416000},"page":"469-473","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["I-FiBH trial: intravenous fluids in benign headaches\u2014a randomised, single-blinded clinical trial"],"prefix":"10.1136","volume":"37","clinical-trial-number":[{"clinical-trial-number":"nct03185130","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-6611","authenticated-orcid":false,"given":"Tony","family":"Zitek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Martin Manuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanhha","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"2024102506225360000_37.8.469.1","unstructured":"National Hospital ambulatory medical care survey: 2016 emergency department summary tables. Available: https:\/\/www.cdc.gov\/nchs\/data\/nhamcs\/web_tables\/2016_ed_web_tables.pdf [Accessed 12 Jul 2019]."},{"key":"2024102506225360000_37.8.469.2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ajem.2017.01.030","article-title":"Epidemiology of intravenous fluid use for headache treatment: findings from the National Hospital ambulatory medical care survey","volume":"35","author":"Jones","year":"2017","journal-title":"Am J Emerg Med"},{"key":"2024102506225360000_37.8.469.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05143_3.x"},{"key":"2024102506225360000_37.8.469.4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ajem.2018.08.051","article-title":"Ed treatment of migraine patients has changed","volume":"37","author":"Ruzek","year":"2019","journal-title":"Am J Emerg Med"},{"key":"2024102506225360000_37.8.469.5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.annemergmed.2018.09.004","article-title":"Intravenous fluid for the treatment of emergency department patients with migraine headache: a randomized controlled trial","volume":"73","author":"Jones","year":"2019","journal-title":"Ann Emerg Med"},{"key":"2024102506225360000_37.8.469.6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/head.12443","article-title":"Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine","volume":"54","author":"Richer","year":"2014","journal-title":"Headache"},{"key":"2024102506225360000_37.8.469.7","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413485658"},{"key":"2024102506225360000_37.8.469.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420080094038"},{"key":"2024102506225360000_37.8.469.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2001.tb01147.x"},{"key":"2024102506225360000_37.8.469.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2013.03.017"},{"key":"2024102506225360000_37.8.469.11","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2002.000356"},{"key":"2024102506225360000_37.8.469.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.1998.tb02463.x"},{"key":"2024102506225360000_37.8.469.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.11.020"},{"key":"2024102506225360000_37.8.469.14","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2003.195"},{"key":"2024102506225360000_37.8.469.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2007.09.047"},{"key":"2024102506225360000_37.8.469.16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1212\/WNL.0000000000004642","article-title":"Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine","volume":"89","author":"Friedman","year":"2017","journal-title":"Neurology"},{"key":"2024102506225360000_37.8.469.17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.annemergmed.2017.08.063","article-title":"A Comparison of Headache Treatment in the Emergency Department: Prochlorperazine Versus Ketamine","volume":"71","author":"Zitek","year":"2018","journal-title":"Ann Emerg Med"},{"key":"2024102506225360000_37.8.469.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2007.09.027"},{"key":"2024102506225360000_37.8.469.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(95)70001-3"},{"key":"2024102506225360000_37.8.469.20","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.113032"},{"key":"2024102506225360000_37.8.469.21","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.118863"},{"key":"2024102506225360000_37.8.469.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2009.00581.x"},{"key":"2024102506225360000_37.8.469.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2015.12.080"},{"key":"2024102506225360000_37.8.469.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04014.x"},{"key":"2024102506225360000_37.8.469.25","unstructured":"Detailed price list . Available: https:\/\/core.secure.ehc.com\/src\/util\/detail-price-list\/EastFloridaDivision_KendallRegionalMedicalCenter_CM.csv [Accessed 24 Feb 2020]."},{"key":"2024102506225360000_37.8.469.26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jemermed.2017.12.023","article-title":"Benign headache management in the emergency department","volume":"54","author":"Long","year":"2018","journal-title":"J Emerg Med"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2019-209389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T13:25:13Z","timestamp":1729862713000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2019-209389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,7,24]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/emermed-2019-209389"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2019-209389","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]}}}